Safety, pharmacokinetics and pharmacodynamics of multiple‐ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus
暂无分享,去创建一个
L. Morrow | E. Norjavaara | H. Ericsson | M. Hompesch | M. Wollbratt | M. Knutsson | M. Leonsson-Zachrisson